IFIGENEIA in Media
The IFIGENEIA project is gaining visibility across media channels, showcasing its role in advancing research, innovation and societal impact.
This section gathers selected media coverage highlighting project activities, results and outreach across Europe and beyond.
The IFIGENEIA project is gaining visibility across media channels, showcasing its role in advancing research, innovation and societal impact.
This section gathers selected media coverage highlighting project activities, results and outreach across Europe and beyond.
Inovacije, most med znanostjo in gospodarstvom
Innovation, a Bridge Between Science and Industry
24 April 2026
Newspaper Dnevnik
The IFIGENEIA project strengthens the connection between science and industry in nuclear medicine, with a strong focus on innovation and collaboration. It also highlights the growing demand for radioisotopes in Europe and the need for more reliable, locally supported production.
24 April 2026
Newspaper Dnevnik
Inovacije, most med znanostjo in gospodarstvom
Innovation, a Bridge Between Science and Industry
The IFIGENEIA project strengthens the connection between science and industry in nuclear medicine, with a strong focus on innovation and collaboration. It also highlights the growing demand for radioisotopes in Europe and the need for more reliable, locally supported production.
Slovensko partnerstvo pridobilo financiranje evropskega projekta IFIGENEIA
Slovenian partnership awarded funding for the European project IFIGENEIA
31 March 2025
Znanost.sta.si
Coverage highlights the successful acquisition of European funding for the IFIGENEIA project, involving Slovenian and international partners. It outlines the development of innovative accelerator-based solutions for radioisotope production. The project addresses current shortages and aims to strengthen healthcare capabilities.
31 March 2025
Znanost.sta.si
Slovensko partnerstvo pridobilo financiranje evropskega projekta IFIGENEIA
Slovenian partnership awarded funding for the European project IFIGENEIA
Coverage highlights the successful acquisition of European funding for the IFIGENEIA project, involving Slovenian and international partners. It outlines the development of innovative accelerator-based solutions for radioisotope production. The project addresses current shortages and aims to strengthen healthcare capabilities.
Slovensko partnerstvo pridobilo financiranje evropskega projekta IFIGENEIA
Slovenian partnership awarded funding for the European project IFIGENEIA
31 March 2025
Gorenjskiglas.si
Focus is placed on the involvement of Slovenian partners within the wider European IFIGENEIA consortium. The content presents efforts to advance sustainable radioisotope production and strengthen nuclear medicine infrastructure. The initiative contributes to improved research and healthcare capacity.
31 March 2025
Gorenjskiglas.si
Slovensko partnerstvo pridobilo financiranje evropskega projekta IFIGENEIA
Slovenian partnership awarded funding for the European project IFIGENEIA
Focus is placed on the involvement of Slovenian partners within the wider European IFIGENEIA consortium. The content presents efforts to advance sustainable radioisotope production and strengthen nuclear medicine infrastructure. The initiative contributes to improved research and healthcare capacity.
Slovensko partnerstvo pridobilo financiranje evropskega projekta IFIGENEIA
Slovenian partnership awarded funding for the European project IFIGENEIA
31 March 2025
STA.si
Introduces the launch of the IFIGENEIA project and the role of Slovenian institutions in an international research collaboration. Emphasis is given to the development of new technologies for radioisotope production. The project responds to key challenges in nuclear medicine and access to treatment.
31 March 2025
STA.si
Slovensko partnerstvo pridobilo financiranje evropskega projekta IFIGENEIA
Slovenian partnership awarded funding for the European project IFIGENEIA
Introduces the launch of the IFIGENEIA project and the role of Slovenian institutions in an international research collaboration. Emphasis is given to the development of new technologies for radioisotope production. The project responds to key challenges in nuclear medicine and access to treatment.
Slovensko partnerstvo pridobilo financiranje evropskega projekta IFIGENEIA
Slovenian partnership awarded funding for the European project IFIGENEIA
31 March 2025
Megafon.si
Reports on the funding and launch of the IFIGENEIA project within a broad European partnership. The content outlines efforts to develop sustainable and accessible solutions for radioisotope production. The initiative is expected to enhance diagnostic and treatment capabilities.
31 March 2025
Megafon.si
Slovensko partnerstvo pridobilo financiranje evropskega projekta IFIGENEIA
Slovenian partnership awarded funding for the European project IFIGENEIA
Reports on the funding and launch of the IFIGENEIA project within a broad European partnership. The content outlines efforts to develop sustainable and accessible solutions for radioisotope production. The initiative is expected to enhance diagnostic and treatment capabilities.
Slovenski partnerji sodelujejo pri vzpostavitvi centra odličnosti za trajnostno proizvodnjo radioizotopov
Slovenian partners are contributing to the establishment of a Centre of Excellence for sustainable radioisotope production
26 March 2025
Uni-lj.si
Highlights the role of Slovenian partners in establishing centres of excellence for sustainable radioisotope production. Collaboration between research, healthcare and industry stakeholders is emphasised. The project supports long-term development of infrastructure and innovation in nuclear medicine.
26 March 2025
Uni-lj.si
Slovenski partnerji sodelujejo pri vzpostavitvi centra odličnosti za trajnostno proizvodnjo radioizotopov
Slovenian partners are contributing to the establishment of a Centre of Excellence for sustainable radioisotope production
Highlights the role of Slovenian partners in establishing centres of excellence for sustainable radioisotope production. Collaboration between research, healthcare and industry stakeholders is emphasised. The project supports long-term development of infrastructure and innovation in nuclear medicine.